Subcutaneous Administration of a 10-Fold-Lower Dose of a Commercial Human Tuberculosis Vaccine, Mycobacterium bovis Bacillus Calmette-Guérin Danish, Induced Levels of Protection against Bovine Tuberculosis and Responses in the Tuberculin Intradermal Test Similar to Those Induced by a Standard Cattle Dose

Lignende værker

• Field Evaluation of the Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin against Bovine Tuberculosis in Neonatal Calves in Ethiopia
  af: Ameni, Gobena, et al.
  Udgivet: (2010)
• Appraisal of Interpretation Criteria for the Comparative Intradermal Tuberculin Test for Diagnosis of Tuberculosis in Cattle in Central Ethiopia
  af: Ameni, Gobena, et al.
  Udgivet: (2008)
• Duration of Immunity against Mycobacterium bovis following Neonatal Vaccination with Bacillus Calmette-Guérin Danish: Significant Protection against Infection at 12, but Not 24, Months
  af: Thom, M. L., et al.
  Udgivet: (2012)
• Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone
  af: Wedlock, D. Neil, et al.
  Udgivet: (2008)
• Tuberculin Skin Testing Boosts Interferon Gamma Responses to DIVA Reagents in Mycobacterium bovis-Infected Cattle
  af: Jones, Gareth J., et al.
  Udgivet: (2017)